177 related articles for article (PubMed ID: 32205534)
1. Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular Carcinoma.
Bell M; Turkbey EB; Escorcia FE
Cancer J; 2020; 26(2):108-115. PubMed ID: 32205534
[TBL] [Abstract][Full Text] [Related]
2. Radiomics in Hepatocellular Carcinoma.
Sagir Kahraman A
J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of
Lee SM; Kim HS; Lee S; Lee JW
World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
[TBL] [Abstract][Full Text] [Related]
4. Radiomics and radiogenomics of primary liver cancers.
Jeong WK; Jamshidi N; Felker ER; Raman SS; Lu DS
Clin Mol Hepatol; 2019 Mar; 25(1):21-29. PubMed ID: 30441889
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Hepatocellular Carcinoma Using C11 Choline PET/CT: Comparison with F18 FDG, ContrastEnhanced MRI and MDCT.
Chotipanich C; Kunawudhi A; Promteangtrong C; Tungsuppawattanakit P; Sricharunrat T; Wongsa P
Asian Pac J Cancer Prev; 2016; 17(7):3569-73. PubMed ID: 27510010
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomics and Its Role in Lymphoma.
Khan S; Naim S; Bilwani R; Salem A; Gorlin D; Muhammad A; Gul M; Imam MH; Chaudhry A
Curr Hematol Malig Rep; 2020 Jun; 15(3):211-224. PubMed ID: 32430588
[TBL] [Abstract][Full Text] [Related]
7. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
9. Low Utility of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography for Detecting Hepatocellular Carcinoma in Patients Before Liver Transplantation.
Alotaibi F; Kabbani M; Abaalkhail F; Chorley A; Elbeshbeshy H; Al-Hamoudi W; Alabbad S; Boehnert MU; Alsofayan M; Al-Kattan W; Ahmed B; Broering D; Al Sebayel M; Elsiesy H
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):37-41. PubMed ID: 28260429
[TBL] [Abstract][Full Text] [Related]
10. Value of ¹⁸F-FDG-PET/CT in the detection of recurrent hepatocellular carcinoma after hepatectomy or radiofrequency ablation: a comparative study with contrast-enhanced ultrasound.
Wang XY; Chen D; Zhang XS; Chen ZF; Hu AB
J Dig Dis; 2013 Aug; 14(8):433-8. PubMed ID: 23615075
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?
Hesketh RL; Zhu AX; Oklu R
Am J Clin Oncol; 2015 Aug; 38(4):431-6. PubMed ID: 25238287
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.
Sumiyoshi T; Moriguchi M; Kanemoto H; Asakura K; Sasaki K; Sugiura T; Mizuno T; Uesaka K
Surg Today; 2012 Jan; 42(2):200-4. PubMed ID: 22160355
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular adenoma showing high uptake of (18)F-fluorodeoxyglucose (FDG) via an increased expression of glucose transporter 2 (GLUT-2).
Nakashima T; Takayama Y; Nishie A; Asayama Y; Baba S; Yamashita Y; Shirabe K; Kubo Y; Hida T; Honda H
Clin Imaging; 2014; 38(6):888-91. PubMed ID: 25034402
[TBL] [Abstract][Full Text] [Related]
14. Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.
Talbot JN; Fartoux L; Balogova S; Nataf V; Kerrou K; Gutman F; Huchet V; Ancel D; Grange JD; Rosmorduc O
J Nucl Med; 2010 Nov; 51(11):1699-706. PubMed ID: 20956466
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
16. Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Dong A; Dong H; Zuo C
Clin Nucl Med; 2014 Jan; 39(1):e69-72. PubMed ID: 23486333
[TBL] [Abstract][Full Text] [Related]
17. Identification of Keratin 19-Positive Cancer Stem Cells Associating Human Hepatocellular Carcinoma Using
Kawai T; Yasuchika K; Seo S; Higashi T; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Nakamoto Y; Hatano E; Uemoto S
Clin Cancer Res; 2017 Mar; 23(6):1450-1460. PubMed ID: 27663597
[No Abstract] [Full Text] [Related]
18. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
19. Role of [
Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the blood supply and efficacy of transcatheter arterial chemoembolization for patients with liver metastasis using
Wang ZF; Fan XX; Xu M; Chen MJ; Zhao ZW; Zhou JD; Tu JF; Song JJ; Hu XH; Lu CY; Wu FZ; Zhang DK; Chen L; Liu L; Ying XH; Xu XF; Ji JS
Tumour Biol; 2017 May; 39(5):1010428317701656. PubMed ID: 28475013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
